 |  |  |  |  |  |
| Protecting the Rights of Shareholders and Consumers |
Immersion Corporation Securities Litigation
Levi & Korsinsky announces that a class action lawsuit has been filed in the United States District Court for the Northern
District of California on behalf of purchasers of the common stock of Immersion Corporation (“Immersion” or the “Company”)
(NasdaqGM: IMMR) between May 3, 2007 and June 30, 2009, inclusive (the “Class Period”).
The complaint alleges that Immersion and certain of its officers and directors violated the Securities Exchange Act of 1934 by
issuing misleading statements concerning the Company's transactions in its Medical line of business. Specifically, the
complaint asserts that defendants failed to disclose that Immersion's revenue recognition policies in its Medical line of
business were improper and violated GAAP and the Company's own internal accounting policies. On July 1, 2009,
Immersion announced that it was conducting an internal investigation into previous revenue transactions in its Medical line
of business. As a result, the Company's stock fell 23%.
If you purchased Immersion common stock during the Class Period and wish to serve as lead plaintiff, you must move the
court by November 2, 2009. A lead plaintiff is a representative party acting on behalf of other class members in directing the
litigation. You do not need to seek appointment as a lead plaintiff in order to share in any recovery.
If you wish to obtain additional information, please fill out the questionnaire below.
District of California on behalf of purchasers of the common stock of Immersion Corporation (“Immersion” or the “Company”)
(NasdaqGM: IMMR) between May 3, 2007 and June 30, 2009, inclusive (the “Class Period”).
The complaint alleges that Immersion and certain of its officers and directors violated the Securities Exchange Act of 1934 by
issuing misleading statements concerning the Company's transactions in its Medical line of business. Specifically, the
complaint asserts that defendants failed to disclose that Immersion's revenue recognition policies in its Medical line of
business were improper and violated GAAP and the Company's own internal accounting policies. On July 1, 2009,
Immersion announced that it was conducting an internal investigation into previous revenue transactions in its Medical line
of business. As a result, the Company's stock fell 23%.
If you purchased Immersion common stock during the Class Period and wish to serve as lead plaintiff, you must move the
court by November 2, 2009. A lead plaintiff is a representative party acting on behalf of other class members in directing the
litigation. You do not need to seek appointment as a lead plaintiff in order to share in any recovery.
If you wish to obtain additional information, please fill out the questionnaire below.
